This Company Made Back Pain Therapies. Now It's Out For A COVID-19 Drug.

Last week, Mesoblast Limited (NASDAQ: MESO) was plugging away at therapies for heart failure, chronic back pain and rheumatoid arthritis.
Source: back pain